PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Consultant Nephrologist, Counties Manukau DHB.\', \'Consultant Nephrologist, Waitematā DHB.\', \'Cardiovascular Physician/Clinical Pharmacologist, Auckland DHB and Sr lecturer, University of Auckland.\', \'Consultant Nephrologist, Northland DHB.\', \'Consultant Nephrologist, Waikato DHB.\', \'Department of Physiology, University of Auckland.\', \'Nurse Specialist, The Hypertension Clinic, Auckland.\', \'Research Operations Manager, Manaaki Mānawa - The Heart Research Centre.\', \'Consultant Hypertension Specialist, The Hypertension Clinic, Auckland.\', \'Director, Manaaki Mānawa - The Heart Research Centre, and Department of Physiology, University of Auckland.\']
?:citedBy
  • -1
?:creator
?:hasPublicationType
?:journal
  • The New Zealand medical journal
is ?:pmid of
?:pmid
?:pmid
  • 32242182
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • A consensus statement on the use of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in relation to COVID-19 (corona virus disease 2019).
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all